A follow-on CT scan can help lower risks of brain hemorrhage for patients with minor head injuries who are taking the anticoagulant warfarin, according to a study published online this week in the Annals of Emergency Medicine.
A follow-on CT scan can help lower risks of brain hemorrhage for patients with minor head injuries who are taking the anticoagulant warfarin, according to a study published online this week in the Annals of Emergency Medicine.
Italian researchers enrolled 97 patients receiving warfarin and showing no intracranial lesions on a first CT scan after minor head injury treated at a level 2 trauma center in Ancona, Italy. After 24 hours of observation, they performed a pre-discharge CT-scan follow up, evaluating the frequency of death, admission, neurosurgery, and delayed intracranial hemorrhage.
Of the 87 patients agreed to the second scan, the follow-on radiology consult revealed a new hemorrhage lesion in five patients (6 percent), with three patients being hospitalized. One received a craniotomy for subdural hematoma.
In addition, two patients discharged after completing the study with two negative CT scan results were readmitted within days with symptomatic subdural hematomas; neither received surgery. Two of the five patients with delayed bleeding at 24 hours had an initial international normalized ratio (INR value) greater than 3.0, as did both patients with delayed bleeding beyond 24 hours. Patients with initial INR value greater than 3.0 were 14 times more likely to have delayed hemorrhage, the researchers found.
Guidelines from the European Federation of Neurological Societies guidelines recommend follow-on CT scans strategy for all patients on blood thinners with minor head injury.
“For patients receiving warfarin who experience minor head injury and have a negative initial head CT scan result, a protocol of 24-hour observation followed by a second CT scan will identify most occurrences of delayed bleeding,” the researchers concluded.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Help Predict Renal Function Decline After Radioligand Therapy for mCRPC?
February 25th 2025In patients who had at least four cycles of 177Lu-PSMA-I&T for mCRPC, new research shows that a 10 percent or greater decrease in total kidney volume on CT at six months has a 90 percent AUC for predicting estimated glomerular filtration rates (eGFRs) of 30 percent or greater at one year.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.